A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

• Status: Terminated
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare efficacy and safety of Exubera® vs Humalog in patients with type 1 diabetes mellitus

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Insulin; Insulin Glargine; Insulin Lispro; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes mellitus Type 1

Exclusion Criteria:

• Severe Asthma, severe Chronic Obstructive Pulmonary Disease (COPD)

• Smoking